Proposed Changes to 340B Could Drive Away a Third of Participating Hospitals

October 28, 2015

Modern Healthcare (Johnson, 10/28) reported that according to 340B Health, 29% of hospitals participating in the 340B Drug Pricing Program would drop out if the Health Resources and Services Administration’s (HRSA) proposed mega guidance was finalized as written. “At issue are new provisions that critics feel narrow the definition of an eligible outpatient under the program. … Proposed changes to billing requirements would ban physicians from ordering 340B drugs if they only have admitting privileges or credentials with a participating hospital.” Ted Slafsky,  CEO of 340B Health, said “that would automatically ban providers located in states where hospitals can't bill for physicians services.”